Urology Medical News about testes

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Management of the residual post-chemotherapy retroperitoneal mass in germ cell tumors
Therapeutic Advances in Urology, 10/08/09

Lavery HJ et al. – The management of the residual mass in the retroperitoneum following induction chemotherapy for metastatic testicular cancer has evolved over the past three decades. The authors will discuss these issues and review the current guidelines for the management of the residual postchemotherapy retroperitoneal mass in this review.

Exclusive Author Commentary
Hugh J. Lavery, 10/12/09

Advanced testicular cancer has been extensively studied, yet remains a complex topic for most practitioners. This review offers a comprehensive analysis of the evidence regarding residual post-chemotherapy retroperitoneal masses that has led to the current standards of care. Areas of persistent controversy and ongoing debate are also addressed.

<< Previous
Overactive bladder in males

Next >>
NBBS isolated from Pygeum africanum bark exhibits androgen...